Condensed Consolidated Statements of Income - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2018	Mar. 31, 2017
Income Statement [Abstract]
Net sales	$ 16,634,067	$ 7,715,955	$ 47,513,371	$ 24,592,043
Cost of sales	11,342,518	5,014,175	32,112,451	16,022,269
Gross profit	5,291,549	2,701,780	15,400,920	8,569,774
Selling, general, and administrative expenses	6,213,490	3,153,257	15,146,001	8,768,851
Research and development expenses	242,306	230,594	1,047,642	818,954
Operating loss	(1,164,247)	(682,071)	(792,723)	(1,018,031)
Other income (expense):
Interest expense, net	(118,045)	(74,992)	(298,559)	(198,084)
Other income, net	4,859	2,332	26,845	80,431
Net other expense	(113,186)	(72,660)	(271,714)	(117,653)
Loss before income taxes	(1,277,433)	(754,731)	(1,064,437)	(1,135,684)
Income tax (provision) benefit	0	0	0	0
Net loss	(1,277,433)	(754,731)	(1,064,437)	(1,135,684)
Deemed dividend on convertible preferred stock and accretion of discount	0	0	(1,023,786)	(375,858)
Preferred stock dividend, cash	0	0	(104,884)	0
Convertible preferred stock dividend, in common stock	(190,523)	(93,979)	(578,178)	(271,756)
Net loss attributable to common stockholders	$ (1,467,956)	$ (848,710)	$ (2,771,285)	$ (1,783,298)
Basic and diluted net loss per common share	$ (0.18)	$ (0.28)	$ (0.45)	$ (0.61)
Weighted-average common shares outstanding:
Basic and diluted	7,962,179	3,022,443	6,135,224	2,914,229